Symbol | YTM % | Price % | Coupon % | Maturity date | Outstanding amt | Face value | Min denom amt | Issuer |
---|---|---|---|---|---|---|---|---|
117RIGLAXOSMITHKLINE CAPITAL PLC 4.25% GTD SNR EMTN 18/12/45 | 5.56% | 82.51% | 4.25% | 2045-12-18 | 370.786 M GBP | 1,000.00 GBP | 100,000.00 GBP | GlaxoSmithKline Capital Plc |
883GIGLAXOSMITHKLINE CAPITAL PLC 5.25% GTD SNR EMTN 10/04/2042 | 5.35% | 98.80% | 5.25% | 2042-04-10 | 477.816 M GBP | 1,000.00 GBP | 50,000.00 GBP | GlaxoSmithKline Capital Plc |
GGSK.GJGlaxoSmithKline Capital, Inc. 6.375% 15-MAY-2038 | 5.34% | 110.30% | 6.38% | 2038-05-15 | 2.75 B USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital, Inc. |
771ZCGLAXOSMITHKLINE CAPITAL PLC 6.375% GTD SNR EMTN 09/03/39 | 5.30% | 111.13% | 6.38% | 2039-03-09 | 631.3 M GBP | 1,000.00 GBP | 50,000.00 GBP | GlaxoSmithKline Capital Plc |
GGSK3981911GlaxoSmithKline Capital, Inc. 4.2% 18-MAR-2043 | 5.29% | 86.48% | 4.20% | 2043-03-18 | 500 M USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital, Inc. |
XXS217060907GLAXOSM.CAP. MTN 20/35MTN | 4.93% | 72.39% | 1.63% | 2035-05-12 | 750 M GBP | 1,000.00 GBP | 100,000.00 GBP | GlaxoSmithKline Capital Plc |
AAG99GLAXOSMITHKLINE CAPITAL PLC 5.25% GTD SNR EMTN 19/12/2033 | 4.75% | 103.73% | 5.25% | 2033-12-19 | 574.166 M GBP | 1,000.00 GBP | 1,000.00 GBP | GlaxoSmithKline Capital Plc |
772WIGLAXOSMITHKLINE CAPITAL INC 5.375% GTD SNR NTS 15/04/2034 | 4.69% | 105.28% | 5.38% | 2034-04-15 | 500 M USD | 1,000.00 USD | 1,000.00 USD | GlaxoSmithKline Capital, Inc. |
UUS377373AH8GLAXOSM.CAP. 19/29 | 4.64% | 94.76% | 3.38% | 2029-06-01 | 1 B USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital Plc |
UUS377372AN7GLAXOSMITHKLINE CAP.18/28 | 4.52% | 97.89% | 3.88% | 2028-05-15 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital, Inc. |
XXS217060184GLAXOSM.CAP. MTN 20/28MTN | 4.44% | 88.42% | 1.25% | 2028-10-12 | 750 M GBP | 1,000.00 GBP | 100,000.00 GBP | GlaxoSmithKline Capital Plc |
GGSK4632357GlaxoSmithKline Capital, Inc. 3.625% 15-MAY-2025 | 4.22% | 99.42% | 3.63% | 2025-05-15 | 1 B USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital, Inc. |
GGX5CGLAXOSM.CAP. MTN 05/25 | 3.27% | 100.72% | 4.00% | 2025-06-16 | 750 M EUR | 1,000.00 EUR | 1,000.00 EUR | GlaxoSmithKline Capital Plc |
XXS255381776GSK CAP B.V. 22/32 MTN | 3.14% | 99.87% | 3.13% | 2032-11-28 | 700 M EUR | 1,000.00 EUR | 100,000.00 EUR | GSK Capital BV |
XXS182282979GLAXOSM.CAP. MTN 18/30MTN | 2.92% | 93.99% | 1.75% | 2030-05-21 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | GlaxoSmithKline Capital Plc |
XXS255381768GSK CAP B.V. 22/27 MTN | 2.77% | 100.68% | 3.00% | 2027-11-28 | 500 M EUR | 1,000.00 EUR | 100,000.00 EUR | GSK Capital BV |
XXS168152035GLAXOSM.CAP. MTN 17/29 | 2.75% | 93.71% | 1.38% | 2029-09-12 | 500 M EUR | 1,000.00 EUR | 100,000.00 EUR | GlaxoSmithKline Capital Plc |
GGX5BGLAXOSM.CAP. MTN 17/26 | 2.67% | 96.98% | 1.00% | 2026-09-12 | 700 M EUR | 1,000.00 EUR | 100,000.00 EUR | GlaxoSmithKline Capital Plc |
XXS182282812GLAXOSM.CAP. MTN 18/26MTN | 2.66% | 97.86% | 1.25% | 2026-05-21 | 1 B EUR | 1,000.00 EUR | 100,000.00 EUR | GlaxoSmithKline Capital Plc |
XXS114760579GLAXOSM.CAP. MTN 14/24 | 1.52% | 99.86% | 1.38% | 2024-12-02 | 1 B EUR | 1,000.00 EUR | 100,000.00 EUR | GlaxoSmithKline Capital Plc |
117RNGLAXOSMITHKLINE CAPITAL PLC 3.375% GTD SNR EMTN 20/12/2027 | −0.49% | 112.19% | 3.38% | 2027-12-20 | 307.77 M GBP | 1,000.00 GBP | 100,000.00 GBP | GlaxoSmithKline Capital Plc |